Literature DB >> 2813784

Myocardial uptake and clearance of T1-201 in healthy subjects: comparison of adenosine-induced hyperemia and exercise stress.

P A Siffring1, N C Gupta, S M Mohiuddin, D J Esterbrooks, D E Hilleman, S C Cheng, M H Sketch, M P Frick.   

Abstract

Pharmacologic stress testing with dipyridamole is useful in patients undergoing thallium-201 myocardial perfusion scintigraphy who cannot adequately exercise. Because dipyridamole increases coronary blood flow by reducing the metabolism of adenosine, the authors compared the uptake and clearance of T1-201 following exercise stress testing (EST) and resting intravenous infusion of adenosine (AI) in crossover fashion in 20 healthy men. No perfusion defects or areas of redistribution were noted in any of the scans. Mean absolute myocardial T1-201 uptake was 1.3 times greater with AI than with EST. Mean absolute extracardiac uptake was 2.0 times greater with AI. Mean T1-201 myocardial clearance was virtually the same in all AI and EST views. During AI, 70% of the subjects experienced subjective side effects, mean arterial blood pressure decreased by 15%, and heart rate increased by 48%. The effects of adenosine on T1-201 kinetics in the myocardium are similar to those of EST. Adenosine may be useful as a pharmacologic stress agent in patients undergoing T1-201 myocardial perfusion scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813784     DOI: 10.1148/radiology.173.3.2813784

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers.

Authors:  T Uematsu; O Kozawa; H Matsuno; M Niwa; H Yoshikoshi; M Oh-uchi; K Kohno; S Nagashima; M Kanamaru
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress.

Authors:  David M Schuster; Raghuveer K Halkar; Fabio P Esteves; Ernest V Garcia; C David Cooke; Mushabbar A Syed; F DuBois Bowman; John R Votaw
Journal:  Mol Imaging Biol       Date:  2008-05-03       Impact factor: 3.488

Review 3.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

Review 4.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

5.  Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging.

Authors:  R Taillefer; R Amyot; S Turpin; R Lambert; C Pilon; M Jarry
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

6.  Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease.

Authors:  A M Kamal; A A Fattah; S Pancholy; S Aksut; V Cave; J Heo; A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

7.  Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging.

Authors:  C D Santos-Ocampo; S D Herman; M I Travin; C E Garber; A W Ahlberg; D E Messinger; G V Heller
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

8.  Variations in the size of the ischemic myocardium due to differences in the normal file.

Authors:  J Lee; B Iskandrian; J Heo; A S Iskandrian
Journal:  Int J Card Imaging       Date:  1993-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.